![Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial]()
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trialBoyle, Eileen M.; Leleu, Xavier; Petillon, Marie-Odile; Karlin, Lionel; Doyen, Chantal; Demarquette, Hélène; Royer, Bruno; Macro, Margaret; Moreau, Philippe; Fostier, Karel; Marie-Lorraine, Chretien; Zarnitsky, Charles; Perrot, Aurore; Herbaux, Charles; Poulain, Stephanie; Manier, Salomon; Beauvais, David; Walker, Brian A.; Wardell, Christopher P.; Vincent, Laure; Frenzel, Laurent; Caillon, Hélène; Susanna, Schraen; Dejoie, Thomas; Avet-Loiseau, Hervé; Mohty, Mohamad; Facon, Thierry · British Journal of Haematology · 2019